Clinical Proteomics: Revolutionizing Disease Detection and Patient Tailoring Therapy

Emanuel Petricoin*, Julia Wulfkuhle, Virginia Espina, Lance A. Liotta

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

91 Scopus citations

Abstract

The evolving discipline of Clinical Proteomics is more than simply describing and enumerating the systematic changes in the protein constituency of a cell, or just generating lists of proteins that increase or decrease in expression as a cause or consequence of disease. Clinical applications of proteomics involve the use of proteomic technologies at the bedside with the ultimate goal to characterize the information flow through the intra- and extracellular molecular protein networks that interconnect organ and circulatory systems together. These networks are both new targets for therapeutics themselves as well as underpin the dynamic changes that give rise to cascades of new diagnostic biomarkers. The analysis of human cancer can be used as a model for how clinical proteomics is having an impact at the bedside for early detection, rational therapeutic targeting, and patient-tailored therapy.

Original languageEnglish
Pages (from-to)209-217
Number of pages9
JournalJournal of Proteome Research
Volume3
Issue number2
DOIs
StatePublished - Mar 2004
Externally publishedYes

Keywords

  • Mass spectrometry
  • Patterns
  • Pharmacoproteomics
  • Protein microarrays
  • Proteomics

Fingerprint

Dive into the research topics of 'Clinical Proteomics: Revolutionizing Disease Detection and Patient Tailoring Therapy'. Together they form a unique fingerprint.

Cite this